Cathepsin B protein levels in endometrial cancer: Potential value as a tumour biomarker

Gynecologic Oncology

Volumn 112, Issue 3, 2009, Pages 531-536

  Devetzi, Marina ^a   Scorilas, Andreas ^b   Tsiambas, Evangelos ^c   Sameni, Mansoureh ^d   Fotiou, Stelios ^e   Sloane, Bonnie F ^d   Talieri, Maroulio ^a  

^a SAINT SAVVAS HOSPITAL   (Greece)

^b UNIVERSITY OF ATHENS   (Greece)

^c 417 VA Hospital (NIMTS)   (Greece)

^d WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

Cathepsin B; Endometrial cancer; Immunohistochemistry

Indexed keywords

CATHEPSIN B; ESTROGEN RECEPTOR; PARAFFIN; PROGESTERONE RECEPTOR; TUMOR MARKER;

ADULT; AGED; ARTICLE; CANCER INVASION; CANCER SURVIVAL; CANCER TISSUE; CONTROLLED STUDY; DIAGNOSTIC VALUE; DISEASE FREE SURVIVAL; ENDOMETRIUM; ENDOMETRIUM CARCINOMA; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOPEROXIDASE STAINING; IMMUNOREACTIVITY; MAJOR CLINICAL STUDY; MULTIVARIATE ANALYSIS; OVERALL SURVIVAL; PRIORITY JOURNAL; PROTEIN EXPRESSION; STROMA; TISSUE LEVEL; UNIVARIATE ANALYSIS;

ADULT; AGED; AGED, 80 AND OVER; CATHEPSIN B; CELL MEMBRANE; CYTOPLASM; DISEASE-FREE SURVIVAL; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; NEOPLASM STAGING; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; TUMOR MARKERS, BIOLOGICAL;

EID: 60449090303     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2008.10.030     Document Type: Article

References (24)

1. Nasu K., Kai K., Fujisawa K., Takai N., Nishihiro Y., and Miyakawa I. Expression of cathepsin L in normal endometrium and endometrial cancer. Eur. J. Obstet. Gynecol. Reprod. Biol. 99 (2001) 102-105
2. Mylonas I., Makovitzky J., Richter D.U., Jeschke U., Briese V., and Friese K. Cathepsin D expression in normal, hyperplastic and malignant endometrial tissue: an immunohistochemical analysis. Acta Histochem. 105 (2003) 245-252
3. Aglund K., Rauvala M., Puistola U., Angstrom T., Turpeenniemi-Hujanen T., Zackrisson B., et al. Gelatinases A and B (MMP-2 and MMP-9) in endometrial cancer-MMP-9 correlates to the grade and the stage. Gynecol. Oncol. 94 (2004) 699-704
4. Sanseverino F., Santopietro R., Torricelli M., D'Andrilli G., Russo G., Cevenini G., et al. pRb2/p130 and VEGF expression in endometrial carcinoma in relation to angiogenesis and histopathologic tumour grade. Cancer Biol. Ther. 5 (2006) 84-88
5. Santin A.D., Diamandis E.P., Bellone S., Soosaipillai A., Cane S., Palmieri M., et al. Human kallikrein 6: a new potential serous biomarker for uterine serous papillary cancer. Clin. Cancer Res. 11 (2005) 3320-3325
6. Roshy S., Sloane B.F., and Moin K. Pericellular cathepsin B and malignant progression. Cancer Metastasis Rev. 22 (2003) 271-286
7. Stahl S., Reinders Y., Asan E., Mothes W., Conzelmann E., Sickmann A., et al. Protemic analysis of cathepsin B and L-deficient mouse brain lysosomes. Biochim. Biophys. Acta 1774 (2007) 1237-1246
8. Stoka V., Turk V., and Turk B. Lysosomal cysteine cathepsins: signaling pathways in apoptosis. Biol. Chem. 388 (2007) 555-560
9. Vasiljeva O., and Turk B. Dual contrasting roles of cysteine cathepsins in cancer progression: Apoptosis versus tumour invasion. Biochimie 90 (2008) 380-386
10. Mignatti P., and Rifkin D.B. Biology and biochemistry of proteinases. Physiol. Rev. 73 (1993) 161-195
11. Jedeszko C., and Sloane B.F. Cysteine cathepsins in human cancer. Biol. Chem. 385 (2004) 1017-1027
12. Mohamed M.M., and Sloane B.F. Cysteine cathepsins: multifunctional enzymes in cancer. Nat. Rev., Cancer 6 (2006) 764-775
13. Talieri M., Papadopoulou S., Scorilas A., Xynopoulos D., Arnogianaki N., Plataniotis G., et al. Cathepsin B and cathepsin D expression in the progression of colorectal adenoma to carcinoma. Cancer Lett. 205 (2004) 97-106
14. Scorilas A., Fotiou S., Tsiambas E., Yotis J., Kotsiandri F., Sameni M., et al. Determination of cathepsin B expression may offer additional prognostic information for ovarian cancer patients. Biol. Chem. 363 (2002) 1297-1303
15. Jokimaa V., Osksjoki S., Kujari H., Vuorio E., and Anttila L. Expression patterns of cathepsins B, H, K, L, and S in the human endometrium. Mol. Hum. Reprod. 7 (2001) 73-78
16. Bradley W.H., Lima P.H., Rodgers L., Blomquist C.H., and Downs L.S. Endometrial carcinoma expresses an increased cathepsin B/D ratio. Gynecol. Oncol. 108 (2008) 84-89
17. Sobin L.H., and Wittekind C. TNM classification of malignant tumours (2002), John Wiley, Hoboken (nj)
18. FIGO. Stages announcements-revision. Gynecol. Oncol. 35 (1989) 125-127
19. Campo E., Munoz J., Miquel R., Palacin A., Cardesa A., Sloane B.F., et al. Cathepsin B expression in colorectal carcinomas correlates with tumour progression and shortened patient survival. Am. J. Pathol. 145 (1994) 301-309
20. Scorilas A., Karameris A., Arnogiannaki N., Ardavanis A., Bassilopoulos P., Trangas T., et al. Overexpression of matrix-metalloproteinase-9 in human breast cancer: a potential favourable indicator in node-negative patients. Br. J. Cancer 84 (2001) 1488-1496
21. Kaplan E.L., and Meier P. Non parametric estimation from incomplete observations. J. Am. Stat. Assoc. 53 (1985) 457-481
22. Hecht J., and Mutter G. Molecular and pathological aspects of endometrial carcinogenesis. J. Clin. Oncol. 24 (2006) 4783-4791
23. Dotters D.J. Preoperative CA 125 in endometrial cancer: is it useful?. Am. J. Obstet. Gynecol. 182 (2000) 1328-1334
24. DeClerck Y., Mercurio A., Stack S., Chapman H., Zutter M., Muschel R., et al. Proteases, extracellular matrix and cancer. a workshop of the Path B study section. Am. J. Pathol. 164 (2004) 1131-1139